endobal-logo-E.png

endobal-als-cure-newest.png

 

The Therapeutic Potential of ENDOBAL™ Stems From It's Ability To Combat Key Drivers of Neurodegeneration, Including: 

  • Excitotoxicity: Overstimulation by neurotransmitters like glutamate that causes nerve damage.
  • Neuroinflammation: Inflammation of the nervous tissue.
  • Oxidative stress: Damage caused by unstable molecules called free radicals. 

Supporting Neurological Health: An Introduction to ENDOBAL for ALS

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease affecting nerve cells in the brain and spinal cord, leading to a gradual loss of muscle control. While challenging, ongoing research continues to explore avenues for supportive care. ENDOBAL for ALS is a non-prescription oral drop formulation designed to complement a holistic wellness approach, aiming to support neurological health by targeting key processes associated with neurodegenerative conditions. It is intended for use alongside lifestyle adjustments including avoiding toxins, maintaining a healthy diet, and engaging in increased physical activity.

Anti-inflammatory Action

Neuroinflammation, a persistent immune response within the brain and spinal cord, is a significant contributor to the progression of neurodegenerative diseases like ALS. ENDOBAL for ALS is formulated to help reduce this neuroinflammation. By mitigating excessive inflammatory responses and aiming to reduce microglial activation – a process where immune cells in the brain become overactive and contribute to neural damage – ENDOBAL® seeks to create a more supportive environment for nerve cells.

Antioxidant Support

Oxidative stress, an imbalance between free radicals and antioxidants in the body, is another critical factor implicated in neurodegeneration. This cellular stress can damage neurons and accelerate disease progression. ENDOBAL for ALS is designed to act as an antioxidant, helping to combat oxidative stress. By reducing the burden of harmful free radicals, it aims to protect neuronal integrity and function, thereby contributing to overall brain health.

Neuroprotection

As a neuroprotectant, ENDOBAL for ALS works to safeguard neurons from damage and degeneration. This protective effect is achieved primarily through its anti-inflammatory and antioxidant properties. By reducing oxidative stress and inflammation in the brain, it may help to combat the underlying mechanisms of neurodegenerative diseases. Furthermore, ENDOBAL aims to mitigate the toxic effects that can lead to neuronal damage, reinforcing the brain's natural defenses and potentially combating the effects of amyloid beta and reducing microglial activation.

Promoting Neurogenesis

Neurogenesis, the fascinating process of generating new neurons in the brain, is crucial for repair and regeneration. ENDOBAL for ALS is designed to promote neurogenesis. By potentially influencing neural stem/progenitor cells, ENDOBAL seeks to support the brain’s intrinsic capacity for regeneration. This could contribute to strengthening and protecting the nervous system, offering a novel approach to neurological support.

Dosage and Product Selection

ENDOBAL for ALS is administered as 0.5mL oral drops, taken twice daily for a continuous 30-day supply. To ensure optimal support, ENDOBAL offers tailored dosages based on body weight:

Body Weight     Recommended Dose (per 0.5mL) Per Bottle
Up to 125 lbs  75mg per dose 4500mg
Up to 175 lbs 100mg per dose 6000mg
Up to 250 lbs 150mg per dose 9000mg

 

 

 

ENDOBAL for ALS represents a promising non-prescription option for individuals seeking to support their neurological health. By addressing critical factors like neuroinflammation and oxidative stress, providing neuroprotective benefits, and promoting neurogenesis, it offers a multi-faceted approach. When integrated with a healthy lifestyle, ENDOBAL for ALS aims to contribute to an improved quality of life and sustained well-being.

 

ENDOBAL™ is a groundbreaking product that operates by specifically targeting the endocannabinoid system. Through its interaction with the CB1 and CB2 receptors, it effectively reduces neuroinflammation and oxidative stress by modulating glutamate production and intake. This unique mechanism of action provides neuroprotection to motor neurons and promotes neurogenesis in brain regions critical for motor function. By harnessing the power of the endocannabinoid system, ENDOBAL™ offers a promising solution for those seeking relief from neurological disorders and motor dysfunction. With its targeted approach and proven efficacy, ENDOBAL™ is poised to make a significant impact in the field of neuroscience and medicine.

When taken as a standalone treatment, ENDOBAL™ has not been linked to any major long-term side effects, offering a reassuring safety profile. However, it is critically important to understand that ENDOBAL™ can interact with other medications you may be taking. These interactions have the potential to significantly alter the effectiveness of your current prescriptions.

Therefore, to ensure your health and the optimal efficacy of all your treatments, patients are strongly advised to proactively consult with a qualified Cannabinoid Specialist or their referring healthcare provider. It is essential to provide a comprehensive list of all current medications during this consultation, allowing for a thorough discussion of potential interactions and fostering safe, effective therapeutic outcomes.

 

~Research suggests that excitotoxicity, especially involving glutamate, plays a critical role in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS), leading to motor neuron degeneration.


~The endocannabinoid system (ECS) has been implicated as a potential therapeutic target for ALS, with evidence suggesting that manipulation of this system may offer neuroprotective effects.

 

endobal-logo2.png

 

World's 1st ECS targeted Treatment for ALS

Potential benefits of ENDOBAL™ for ALS

Disease modification:

  • Antioxidative and anti-inflammatory: Endobal can reduce neuroinflammation and oxidative damage, which are key factors in motor neuron death in ALS.
  • Neuroprotection: Endobal may prolong neuronal cell survival by reducing excitotoxicity and activating protective pathways.
  • Delaying progression: Studies in mouse models have shown that cannabinoids in Endobal can delay the onset and slow the progression of the disease.

Potential benefits of ENDOBAL™ for ALS

Symptom management:

  • Pain: Endobal™ has analgesic properties that may help manage chronic pain.
  • Spasticity: Endobal has shown promise in helping with muscle stiffness and spasticity common in ALS.
  • Sleep: Endobal can improve sleep quality, which is often affected by ALS symptoms.
  • Appetite and nausea: Endobal may help stimulate appetite, which is often reduced in patients with ALS.
  • Other symptoms: Endobal can also help with other symptoms like anxiety and muscle cramps
  • ENDOBAL™ has Anti-Glutamatergic Properties

    ENDOBAL™ has Anti-Glutamatergic Properties

    ENDOBAL™ has been shown to reduce the expression of glutamate release genes and has neuroprotective effects through mechanisms like activating PPARγ, an anti-inflammatory pathway

  • ENDOBAL™ has Neuroprotective Properties

    ENDOBAL™ has Neuroprotective Properties

    ENDOBAL™ achieves these effects by interacting with the endocannabinoid system, activating specific receptors, and enhancing cellular processes like autophagy.

  • ENDOBAL™ has Antioxidant Properties

    ENDOBAL™ has Antioxidant Properties

    ENDOBAL™ possess antioxidant properties that can help combat oxidative stress in the body by scavenging free radicals, reducing metal ions, and inhibiting oxidation processes. These compounds have shown potential therapeutic applications by protecting against oxidative damage, which is a factor in various diseases, including neurological disorders, inflammation, and cancer.

cannabinoid-oil.png

ENDOBAL-LOGO.png

Endobal™ harnesses the power of phytocannabinoids to engage the Endocannabinoid System (ECS), a vital regulatory network linked to neurological health and balance, offering a targeted approach for managing conditions like Amyotrophic Lateral Sclerosis (ALS). By modulating the ECS, Endobal™ supports neuroprotection, safeguarding nerve cells from progressive damage while reducing harmful inflammation—a key driver of disease progression. Its antioxidant properties further combat oxidative stress, a contributor to cellular deterioration, while helping regulate glutamate levels to prevent excitotoxicity, a process that accelerates motor neuron decline. This multi-faceted mechanism positions Endobal™ as a promising tool in addressing the complex pathways underlying ALS, offering hope for slowing disease advancement and improving quality of life.

The Battle Against ALS Starts With Endobal

Purchase Endobal™ Without A Prescription

Endobal™ Available by Monthly Subscription.

LEARN MORE

Buy ENDOBAL Monthly with Auto-Reorder Subscription

CLICK HERE

Consult with an Endobal™ Representative

BOOK A CONSULTATION

Endobal™ is available without a prescription or a doctors recommendation. There are no known damaging side-effects or drug interactions. For concerns of drug interactions, a consultation is recommended before subscribing. If you experience any unwanted side-effects or negative drug interactions, stop taking Endobal™, If your negative symptoms persist after you stopped Endobal™ for more then 24 hours, contact us immediately using the form below.

In the case of an Emergency, contact your local Emergency Services


 

endobal-research.png

endobal-logo2.pngResearch Study Trials

Sign Up